{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:47:53Z","timestamp":1787496473121,"version":"build-2736575974"},"reference-count":146,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T00:00:00Z","timestamp":1618185600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.tranon.2021.101101","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T04:54:32Z","timestamp":1619499272000},"page":"101101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Non-coding RNAs in cancer-associated cachexia: clinical implications and future perspectives"],"prefix":"10.1016","volume":"14","author":[{"given":"Anastasia","family":"Kottorou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2402-2549","authenticated-orcid":false,"given":"Foteinos-Ioannis","family":"Dimitrakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aspasia","family":"Tsezou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2021.101101_bib0001","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.tranon.2021.101101_bib0002","first-page":"213","article-title":"Malnutrition, fatigue, frailty, vulnerability, sarcopenia and cachexia: overlap of clinical features","author":"Jeejeebhoy","year":"2012","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care."},{"key":"10.1016\/j.tranon.2021.101101_bib0003","doi-asserted-by":"crossref","first-page":"622","DOI":"10.7326\/0003-4819-133-8-200010170-00015","article-title":"Cachexia","author":"Kotler","year":"2000","journal-title":"Ann. Intern. Med"},{"key":"10.1016\/j.tranon.2021.101101_bib0004","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.tranon.2021.101101_bib0005","first-page":"400","article-title":"Cachexia: prevalence and impact in medicine","author":"Tan","year":"2008","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care."},{"key":"10.1016\/j.tranon.2021.101101_bib0006","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/0884533616680354","article-title":"Differentiating sarcopenia and cachexia among patients with cancer [internet]","author":"Peterson","year":"2017","journal-title":"Nutr. Clin. Pract."},{"key":"10.1016\/j.tranon.2021.101101_bib0007","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0008","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000490361","article-title":"Sarcopenic obesity: time to meet the challenge [Internet]","author":"Barazzoni","year":"2018","journal-title":"Obes. Facts"},{"key":"10.1016\/j.tranon.2021.101101_bib0009","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.tranon.2021.101101_bib0010","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/693458","article-title":"Estimation of cachexia among cancer patients based on four definitions","author":"Fox","year":"2009","journal-title":"J Oncol [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0011","series-title":"Orphan Disease Status of Cancer Cachexia in the USA And in the European Union: A Systematic Review","author":"Anker","year":"2019"},{"key":"10.1016\/j.tranon.2021.101101_bib0012","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/jcsm.12565","article-title":"The expression landscape of cachexia-inducing factors in human cancers","volume":"11","author":"Freire","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0013","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0149-2918(05)80001-3","article-title":"Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative oncology group","volume":"69","author":"Dewys","year":"1980","journal-title":"Am J Med [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0014","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.coph.2015.04.003","article-title":"Cachexia and sarcopenia: Mechanisms and potential targets for intervention","author":"Argil\u00e9s","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.tranon.2021.101101_bib0015","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1200\/JOP.2017.025221","article-title":"Prevalence and survival impact of pretreatment cancer-associated weight loss: a tool for guiding early palliative care","volume":"14","author":"Gannavarapu","year":"2018","journal-title":"J Oncol Pract [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0016","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","article-title":"Understanding the mechanisms and treatment options in cancer cachexia","author":"Fearon","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.tranon.2021.101101_bib0017","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/hed.23023","article-title":"Clinical determinants of weight loss in patients receiving radiation and chemoirradiation for head and neck cancer: a prospective longitudinal view","volume":"35","author":"Kubrak","year":"2013","journal-title":"Head Neck. Head Neck;"},{"key":"10.1016\/j.tranon.2021.101101_bib0018","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/hed.20607","article-title":"Changes in body mass, energy balance, physical function, and inflammatory state in patients with locally advanced head and neck cancer treated with concurrent chemoradiation after low-dose induction chemotherapy","volume":"29","author":"Silver","year":"2007","journal-title":"Head Neck. Head Neck;"},{"key":"10.1016\/j.tranon.2021.101101_bib0019","article-title":"Modeling the energetic cost of cancer as a result of altered energy metabolism: Implications for cachexia","volume":"12","author":"Friesen","year":"2015","journal-title":"Theor Biol Med Model [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0020","article-title":"Tumor induces muscle wasting in mice through releasing extracellular Hsp70 and Hsp90","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat Commun [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0021","doi-asserted-by":"crossref","first-page":"H466","DOI":"10.1152\/ajpheart.00720.2015","article-title":"The pathogenesis and treatment of cardiac atrophy in cancer cachexia [Internet]","author":"Murphy","year":"2016","journal-title":"Am. J. Physiol. - Hear. Circ. Physiol"},{"key":"10.1016\/j.tranon.2021.101101_bib0022","first-page":"4138","article-title":"Role of prostaglandins in the production of hypercalcemia by tumors","volume":"38","author":"Tashjian","year":"1978","journal-title":"Cancer Res. [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0023","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: mediators, signaling, and metabolic pathways [Internet]","author":"Fearon","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.tranon.2021.101101_bib0024","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.semcdb.2015.10.038","article-title":"The central role of hypothalamic inflammation in the acute illness response and cachexia [Internet]","author":"Burfeind","year":"2016","journal-title":"Semin. Cell Dev. Biol"},{"key":"10.1016\/j.tranon.2021.101101_bib0025","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1210\/en.2009-1135","article-title":"Arcuate nucleus proopiomelanocortin neurons mediate the acute anorectic actions of leukemia inhibitory factor via gp130","volume":"151","author":"Grossberg","year":"2010","journal-title":"Endocrinology [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0026","first-page":"6280","article-title":"Mediation of anorexia by human recombinant tumor necrosis factor through a peripheral action in the rat","volume":"49","author":"Bodnar","year":"1989","journal-title":"Cancer Res [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0027","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1084\/jem.20111020","article-title":"Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic-pituitary-adrenal axis","volume":"208","author":"Braun","year":"2011","journal-title":"J Exp Med [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0028","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1002\/cncr.21013","article-title":"Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care - correlations with food intake, metabolism, exercise capacity, and hormones","volume":"103","author":"Fouladiun","year":"2005","journal-title":"Cancer [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0029","first-page":"214","article-title":"Computational modeling of cancer cachexia [Internet]","author":"Hall","year":"2008","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care."},{"key":"10.1016\/j.tranon.2021.101101_bib0030","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.3390\/nu7064465","article-title":"Nf-\u03babp65 and expression of its pro-inflammatory target genes are upregulated in the subcutaneous adipose tissue of cachectic cancer patients","volume":"7","author":"Camargo","year":"2015","journal-title":"Nutrients [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0031","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/jcsm.12041","article-title":"White adipose tissue cells and the progression of cachexia: Inflammatory pathways","volume":"7","author":"Neves","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0032","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/nm.4171","article-title":"An AMP-activated protein kinase-stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice","volume":"22","author":"Rohm","year":"2016","journal-title":"Nat Med [Internet]."},{"key":"10.1016\/j.tranon.2021.101101_bib0033","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1126\/science.1100747","article-title":"Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase","volume":"306","author":"Zimmermann","year":"2004","journal-title":"Science (80-) [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0034","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s11745-004-1346-8","article-title":"Effect of cancer cachexia on triacylglycerol\/fatty acid substrate cycling in white adipose tissue","author":"Beck","year":"2004","journal-title":"Lipids [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0035","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.trecan.2016.07.005","article-title":"Cachexia and brown fat: a burning issue in cancer [Internet]","author":"Kir","year":"2016","journal-title":"Trends in Cancer"},{"key":"10.1016\/j.tranon.2021.101101_bib0036","doi-asserted-by":"crossref","DOI":"10.1038\/s41568-020-0251-4","article-title":"Understanding cachexia in the context of metastatic progression","author":"Biswas","year":"2020","journal-title":"Nat. Rev. Cancer."},{"key":"10.1016\/j.tranon.2021.101101_bib0037","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13539-014-0137-y","article-title":"Concurrent evolution of cancer cachexia and heart failure: bilateral effects exist","author":"Kazemi-Bajestani","year":"2014","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.tranon.2021.101101_bib0038","doi-asserted-by":"crossref","first-page":"187","DOI":"10.14740\/wjon1244","article-title":"Low body mass index is an independent prognostic factor in patients with non-small cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitor","volume":"10","author":"Minami","year":"2019","journal-title":"World J Oncol"},{"key":"10.1016\/j.tranon.2021.101101_bib0039","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.chest.2019.04.115","article-title":"Prognostic value of sarcopenia in lung cancer: a systematic review and meta-analysis","volume":"156","author":"Yang","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.tranon.2021.101101_bib0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19102999","article-title":"Impact of sarcopenia as a prognostic biomarker of bladder cancer","author":"Fukushima","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2021.101101_bib0041","first-page":"156.e9","article-title":"Posttherapeutic skeletal muscle mass recovery predicts favorable prognosis in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy","volume":"36","author":"Fukushima","year":"2018","journal-title":"Urol Oncol Semin Orig Investig [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0042","doi-asserted-by":"crossref","first-page":"526","DOI":"10.2214\/AJR.17.18020","article-title":"Progressive sarcopenia in patients with colorectal cancer predicts survival","volume":"210","author":"Deng","year":"2018","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.tranon.2021.101101_bib0043","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s11605-008-0505-z","article-title":"Cachexia worsens prognosis in patients with resectable pancreatic cancer","volume":"12","author":"Bachmann","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.tranon.2021.101101_bib0044","first-page":"13","article-title":"Prognostic significance of CT-determined sarcopenia in patients with advanced gastric cancer","author":"Lee","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.tranon.2021.101101_bib0045","doi-asserted-by":"crossref","first-page":"86","DOI":"10.21037\/apm.2018.08.02","article-title":"Sarcopenia associated with chemotherapy and targeted agents for cancer therapy","author":"Davis","year":"2019","journal-title":"Ann. Palliat. Med"},{"key":"10.1016\/j.tranon.2021.101101_bib0046","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.lungcan.2020.03.003","article-title":"Cachexia - sarcopenia as a determinant of disease control rate and survival in non-small lung cancer patients receiving immune-checkpoint inhibitors","volume":"143","author":"Roch","year":"2020","journal-title":"Lung Cancer"},{"key":"10.1016\/j.tranon.2021.101101_bib0047","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3390\/jcm8040450","article-title":"Association of sarcopenia with and efficacy of anti-PD-1\/PD-L1 therapy in non-small-cell lung cancer","volume":"8","author":"Nishioka","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.tranon.2021.101101_bib0048","article-title":"A multicenter study of body mass index in cancer patients treated with anti-PD-1\/PD-L1 immune checkpoint inhibitors: When overweight becomes favorable","volume":"7","author":"Cortellini","year":"2019","journal-title":"J Immunother Cancer [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0049","doi-asserted-by":"crossref","first-page":"e21507","DOI":"10.1200\/JCO.2020.38.15_suppl.e21507","article-title":"PIOS ratio: predicting the best response of non-small-cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors","volume":"38","author":"Dimitrakopoulos","year":"2020","journal-title":"J Clin Oncol. Am. Soc. Clin. Oncol. (ASCO);"},{"key":"10.1016\/j.tranon.2021.101101_bib0050","article-title":"Pios (Patras immunotherapy score) score is associated with best overall response, progression-free survival, and post-immunotherapy overall survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with anti-program cell death-1 (PD-1)","volume":"12","author":"Dimitrakopoulos","year":"2020","journal-title":"Cancers (Basel) [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0051","article-title":"Sarcopenia and the risk of adverse events in patients treated with immune checkpoint inhibitors: a systematic review","author":"Guzman-Prado","year":"2021","journal-title":"Cancer Immunol Immunother [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0052","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1200\/JCO.2009.24.9730","article-title":"Association of skeletal muscle wasting with treatment with sorafenib in patients with advanced renal cell carcinoma: Results from a placebo-controlled study","volume":"28","author":"Antoun","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.tranon.2021.101101_bib0053","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s00018-008-8432-4","article-title":"Epigenetic mechanisms in mammals [Internet]","author":"Kim","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.tranon.2021.101101_bib0054","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/boc.201200029","article-title":"The methylation landscape of tumour metastasis","volume":"105","author":"Cock-Rada","year":"2013","journal-title":"Biol Cell [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3233\/CBM-2011-0184","article-title":"DNA methylation in early neoplasia","volume":"9","author":"Carmona","year":"2010","journal-title":"Cancer Biomark [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0056","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/jcsm.12478","article-title":"Differentially methylated gene patterns between age-matched sarcopenic and non-sarcopenic women","volume":"10","author":"He","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.tranon.2021.101101_bib0057","first-page":"603","article-title":"Skeletal muscle cells possess a \u2018memory\u2019 of acute early life TNF-\u03b1 exposure: role of epigenetic adaptation","volume":"17","author":"Sharples","year":"2016","journal-title":"Biogerontol. Springer Netherlands;"},{"key":"10.1016\/j.tranon.2021.101101_bib0058","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1113\/expphysiol.2011.061028","article-title":"Sirtuin 1 regulates skeletal myoblast survival and enhances differentiation in the presence of resveratrol","volume":"97","author":"Saini","year":"2012","journal-title":"Exp Physiol [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0059","first-page":"667","article-title":"HDAC11 inhibits myoblast differentiation through repression of myod-dependent transcription","volume":"40","author":"Byun","year":"2017","journal-title":"Mol Cells. Korean Soc. Mole. Cell. Biol.;"},{"key":"10.1016\/j.tranon.2021.101101_bib0060","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1152\/japplphysiol.01031.2014","article-title":"Trichostatin A, a histone deacetylase inhibitor, modulates unloaded-induced skeletal muscle atrophy","volume":"119","author":"Dupr\u00e9-Aucouturier","year":"2015","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.tranon.2021.101101_bib0061","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0062","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2006.09.028","article-title":"Non-coding RNAs: lost in translation?","volume":"386","author":"Costa","year":"2007","journal-title":"Gene [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0063","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrg1527","article-title":"Conserved non-genic sequences - an unexpected feature of mammalian genomes","volume":"6","author":"Dermitzakis","year":"2005","journal-title":"Nat. Rev. Genet [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0064","article-title":"Non-coding RNA","volume":"15","author":"Mattick","year":"2006","journal-title":"Hum Mol Genet [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0065","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1002\/ijc.31977","article-title":"Exosomal circRNA derived from gastric tumor promotes white adipose browning by targeting the miR-133\/PRDM16 pathway","volume":"144","author":"Zhang","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tranon.2021.101101_bib0066","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3390\/cancers12041004","article-title":"The emerging role of micrornas and other non-coding RNAs in cancer cachexia","volume":"12","author":"Santos","year":"2020","journal-title":"Cancers (Basel) [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0067","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis [Internet]","author":"Ha","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tranon.2021.101101_bib0068","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/sj.bjc.6603023","article-title":"MicroRNAs in cell proliferation, cell death, and tumorigenesis","volume":"94","author":"Hwang","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.tranon.2021.101101_bib0069","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/ijc.25014","article-title":"miRNA control of tumor cell invasion and metastasis","volume":"126","author":"Baranwal","year":"2010","journal-title":"Int J Cancer [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0070","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1016\/j.bbagen.2015.09.020","article-title":"MicroRNA expression and protein acetylation pattern in respiratory and limb muscles of Parp-1-\/- and Parp-2-\/- mice with lung cancer cachexia","volume":"1850","author":"Chacon-Cabrera","year":"2015","journal-title":"Biochim Biophys Acta - Gen Subj"},{"key":"10.1016\/j.tranon.2021.101101_bib0071","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1152\/physiolgenomics.00006.2017","article-title":"Cancer cachexia-induced muscle atrophy: evidence for alterations in microRNAs important for muscle size","volume":"49","author":"Lee","year":"2017","journal-title":"Physiol Genomics [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0072","article-title":"MicroRNA-mRNA co-sequencing identifies transcriptional and post-transcriptional regulatory networks underlying muscle wasting in cancer cachexia","volume":"11","author":"Fernandez","year":"2020","journal-title":"Front. Genet. [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0073","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1158\/0008-5472.CAN-13-2817","article-title":"Cancer affects microRNA expression, release, and function in cardiac and skeletal muscle","volume":"74","author":"Chen","year":"2014","journal-title":"Cancer Res. [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0074","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/ijc.32236","article-title":"Cachexia-related long noncoding RNA, CAAlnc1, suppresses adipogenesis by blocking the binding of HuR to adipogenic transcription factor mRNAs","volume":"145","author":"Shen","year":"2019","journal-title":"Int. J. Cancer [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0075","doi-asserted-by":"crossref","first-page":"D142","DOI":"10.1093\/nar\/gkz1022","article-title":"MiRPathDB 2.0: a novel release of the miRNA pathway dictionary database","volume":"48","author":"Kehl","year":"2020","journal-title":"Nucleic Acids Res. [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0076","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2014.00239","article-title":"Mega roles of microRNAs in regulation of skeletal muscle health and disease","author":"Sharma","year":"2014","journal-title":"Front. Physiol. [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0077","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/jcsm.12226","article-title":"The mitochondrial metabolic reprogramming agent trimetazidine as an \u2018exercise mimetic\u2019 in cachectic C26-bearing mice","volume":"8","author":"Molinari","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0078","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/jcsm.12168","article-title":"Small RNAome profiling from human skeletal muscle: novel miRNAs and their targets associated with cancer cachexia","volume":"8","author":"Narasimhan","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.tranon.2021.101101_bib0079","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20081962","article-title":"The pathway to cancer Cachexia: Microrna-regulated networks in muscle wasting based on integrative meta-analysis","author":"Freire","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2021.101101_bib0080","first-page":"116","article-title":"HuR counteracts miR-330 to promote STAT3 translation during inflammation-induced muscle wasting","author":"Mubaid","year":"2019","journal-title":"Proc Natl Acad Sci USA. Natl. Acad. Sci."},{"key":"10.1016\/j.tranon.2021.101101_bib0081","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/jcsm.12512","article-title":"Identification of microRNAs in skeletal muscle associated with lung cancer cachexia","volume":"11","author":"van de Worp","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.tranon.2021.101101_bib0082","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/jcp.26811","article-title":"Adipose tissue dysfunction in cancer cachexia","volume":"234","author":"Daas","year":"2018","journal-title":"J Cell Physiol [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0083","first-page":"306","article-title":"MicroRNA profiling links miR-378 to enhanced adipocyte lipolysis in human cancer cachexia","author":"Kulyt\u00e9","year":"2014","journal-title":"Am. J. Physiol. - Endocrinol Metab"},{"key":"10.1016\/j.tranon.2021.101101_bib0084","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/jcb.26328","article-title":"Identification and functional analysis of a potential key lncRNA involved in fat loss of cancer cachexia","volume":"119","author":"Liu","year":"2018","journal-title":"J. Cell. Biochem. [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0085","article-title":"The long noncoding RNA MALAT1 modulates adipose loss in cancer-associated cachexia by suppressing adipogenesis through PPAR-\u03b3","volume":"18","author":"Han","year":"2021","journal-title":"Nutr. Metab. [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0086","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/jcsm.12227","article-title":"Circulating myomiRs: a new class of biomarkers to monitor skeletal muscle in physiology and medicine [Internet]","author":"Siracusa","year":"2018","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.tranon.2021.101101_bib0087","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/jcsm.12068","article-title":"Evaluation of C-terminal Agrin Fragment as a marker of muscle wasting in patients after acute stroke during early rehabilitation","volume":"7","author":"Scherbakov","year":"2016","journal-title":"J. Cachexia Sarcopenia Muscle [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0088","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/jcsm.12212","article-title":"Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis","volume":"8","author":"Nishikawa","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0089","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/jcsm.12051","article-title":"Biomarkers for physical frailty and sarcopenia: state of the science and future developments [Internet]","author":"Calvani","year":"2015","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.tranon.2021.101101_bib0090","article-title":"MiRNA-130a significantly improves accuracy of SGA nutritional assessment tool in prediction of malnutrition and cachexia in radiotherapy-treated head and neck cancer patients","volume":"10","author":"Powr\u00f3zek","year":"2018","journal-title":"Cancers (Basel) [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0091","first-page":"1555","article-title":"Prognostic impact of sarcopenia and its correlation with circulating miR-21 in colorectal cancer patients","volume":"39","author":"Okugawa","year":"2018","journal-title":"Oncol. Rep. [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0092","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/jcsm.12403","article-title":"Circulating miR-203 derived from metastatic tissues promotes myopenia in colorectal cancer patients","volume":"10","author":"Okugawa","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.tranon.2021.101101_bib0093","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bbrc.2010.08.015","article-title":"Circulating muscle-specific microRNA, miR-206, as a potential diagnostic marker for rhabdomyosarcoma","volume":"400","author":"Miyachi","year":"2010","journal-title":"Biochem. Biophys. Res. Commun. [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0094","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ejca.2010.10.025","article-title":"A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis","volume":"47","author":"Liu","year":"2011","journal-title":"Eur. J. Cancer [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0095","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.3892\/or.2014.3029","article-title":"Serum miR-499 as a novel diagnostic and prognostic biomarker in non-small cell lung cancer","volume":"31","author":"Li","year":"2014","journal-title":"Oncol. Rep. [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0096","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1200\/JCO.2009.24.9342","article-title":"Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer","volume":"28","author":"Hu","year":"2010","journal-title":"J Clin Oncol [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0097","first-page":"3097","article-title":"Decreased serum microRNA-206 level predicts unfavorable prognosis in patients with melanoma","volume":"8","author":"Tian","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol. [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0098","doi-asserted-by":"crossref","first-page":"9","DOI":"10.18632\/oncotarget.424","article-title":"MicroRNA-1\/133a and microRNA-206\/133b clusters: dysregulation and functional roles in human cancers","volume":"3","author":"Nohata","year":"2012","journal-title":"Oncotarget [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0099","first-page":"4194","article-title":"Serum levels of microRNA-133b and microRNA-206 expression predict prognosis in patients with osteosarcoma","volume":"7","author":"Zhang","year":"2014","journal-title":"Int J Clin Exp Pathol [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0100","first-page":"1","article-title":"Cancer cachexia and microRNAs","volume":"2015","author":"Camargo","year":"2015","journal-title":"Mediators Inflamm. [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0101","first-page":"1","article-title":"Noncoding RNAs, emerging regulators of skeletal muscle development and diseases","volume":"2015","author":"Nie","year":"2015","journal-title":"Biomed. Res. Int. [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0102","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3892\/br.2016.725","article-title":"Extracellular vesicle microRNAs mediate skeletal muscle myogenesis and disease (Review)","volume":"5","author":"Wang","year":"2016","journal-title":"Biomed Reports [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0103","article-title":"Exosomes: From garbage bins to promising therapeutic targets","volume":"18","author":"Rashed","year":"2017","journal-title":"Int. J. Mol. Sci. [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0104","article-title":"Focus on extracellular vesicles: Physiological role and signalling properties of extracellular membrane vesicles","volume":"17","author":"Iraci","year":"2016","journal-title":"Int. J. Mol. Sci. [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0105","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1158\/0008-5472.CAN-16-0651","article-title":"Adipocyte exosomes promote melanoma aggressiveness through fatty acid oxidation: a novel mechanism linking obesity and cancer","volume":"76","author":"Lazar","year":"2016","journal-title":"Cancer Res. [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0106","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.tem.2016.10.003","article-title":"Extracellular vesicles: novel mediators of cell communication in metabolic disease [Internet]","author":"Huang-Doran","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.tranon.2021.101101_bib0107","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcdb.2017.01.004","article-title":"Exosomes: key mediators of metastasis and pre-metastatic niche formation","volume":"67","author":"Lobb","year":"2017","journal-title":"Semin Cell Dev Biol [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0108","article-title":"Exosome-derived microRNAs in cancer metabolism: Possible implications in cancer diagnostics and therapy","volume":"49","author":"Tomasetti","year":"2017","journal-title":"Exp Mol Med [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0109","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12943-018-0899-5","article-title":"Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression","volume":"17","author":"Wu","year":"2018","journal-title":"Mol Cancer [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/21623945.2018.1551688","article-title":"Breast cancer-released exosomes trigger cancer-associated cachexia to promote tumor progression","volume":"8","author":"Wu","year":"2019","journal-title":"Adipocyte [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0111","doi-asserted-by":"crossref","first-page":"21274","DOI":"10.1002\/jcp.28732","article-title":"Chronic myeloid leukemia-derived exosomes attenuate adipogenesis of adipose derived mesenchymal stem cells via transporting miR-92a-3p","volume":"234","author":"Wan","year":"2019","journal-title":"J. Cell. Physiol. [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbior.2014.09.013","article-title":"MicroRNA and cancer - a brief overview","volume":"57","author":"Acunzo","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.tranon.2021.101101_bib0113","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1073\/pnas.1402714111","article-title":"Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7","volume":"111","author":"He","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.tranon.2021.101101_bib0114","article-title":"MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response","volume":"109","author":"Fabbri","year":"2012","journal-title":"Proc Natl Acad. Sci. USA [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0115","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4161\/rna.23144","article-title":"A new role for microRNAs, as ligands of Toll-like receptors","volume":"10","author":"Fabbri","year":"2013","journal-title":"RNA Biol [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0116","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41556-019-0311-8","article-title":"Cellular functions of long noncoding RNAs","volume":"21","author":"Yao","year":"2019","journal-title":"Nat Cell Biol [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0117","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/978-1-4939-3378-5_21","article-title":"Analyzing MiRNA\u2013LncRNA interactions","author":"Paraskevopoulou","year":"2016","journal-title":"Methods Mol Biol [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0118","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrg2521","article-title":"Long non-coding RNAs: insights into functions","volume":"10","author":"Mercer","year":"2009","journal-title":"Nat. Rev. Genet. [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0119","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrg3074","article-title":"Non-coding RNAs in human disease","author":"Esteller","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.tranon.2021.101101_bib0120","first-page":"1","article-title":"Importance of long non-coding RNAs in the development and disease of skeletal muscle and cardiovascular lineages","volume":"7","author":"Sweta","year":"2019","journal-title":"Front. Cell. Dev. Biol. [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0121","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/jcsm.12374","article-title":"LncIRS1 controls muscle atrophy via sponging miR-15 family to activate IGF1-PI3K\/AKT pathway","volume":"10","author":"Li","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0122","article-title":"Regulation of skeletal muscle growth by the IGF1-Akt\/PKB pathway: Insights from genetic models","volume":"1","author":"Schiaffino","year":"2011","journal-title":"Skelet Muscle [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0123","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1172\/JCI25735","article-title":"Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth","volume":"116","author":"Dong","year":"2006","journal-title":"J Clin Invest [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0124","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/jcsm.12281","article-title":"A newly identified lncRNA MAR1 acts as a miR-487b sponge to promote skeletal muscle differentiation and regeneration","volume":"9","author":"Zhang","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.tranon.2021.101101_bib0125","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.devcel.2015.05.009","article-title":"A long non-coding RNA, LncMyoD, regulates skeletal muscle differentiation by blocking IMP2-mediated mRNA translation","volume":"34","author":"Gong","year":"2015","journal-title":"Dev. Cell. [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0126","article-title":"The novel roles of circRNAs in human cancer","volume":"18","author":"Shang","year":"2019","journal-title":"Mol Cancer [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0127","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.biopha.2018.12.052","article-title":"The roles of circular RNAs in human development and diseases","volume":"111","author":"Lee","year":"2019","journal-title":"Biomed Pharmacother [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0128","article-title":"Past, present, and future of circ RNA s","volume":"38","author":"Patop","year":"2019","journal-title":"EMBO J [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0129","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2217\/epi-2017-0058","article-title":"Epigenetics of cancer-associated muscle catabolism","author":"Carr","year":"2017","journal-title":"Epigenomics"},{"key":"10.1016\/j.tranon.2021.101101_bib0130","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/131579","article-title":"Synthetic pre-miRNA-based shRNA as potent RNAi triggers","author":"Terasawa","year":"2011","journal-title":"J. Nucleic Acids [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0131","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/17512433.2019.1567326","article-title":"Patisiran for the treatment of hereditary transthyretin-mediated amyloidosis","volume":"12","author":"Yang","year":"2019","journal-title":"Expert Rev. Clin. Pharmacol. [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0132","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3389\/fgene.2019.00478","article-title":"The potential for microRNA therapeutics and clinical research","volume":"10","author":"Hanna","year":"2019","journal-title":"Front Genet [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0133","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10616-012-9430-9","article-title":"A comparative study on nonviral genetic modifications in cord blood and bone marrow mesenchymal stem cells","volume":"64","author":"Bakhshandeh","year":"2012","journal-title":"Cytotechnology [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0134","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat Rev Genet [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0135","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours","volume":"122","author":"Hong","year":"2020","journal-title":"Br J Cancer [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0136","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S1470-2045(17)30621-6","article-title":"Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study","volume":"18","author":"van Zandwijk","year":"2017","journal-title":"Lancet Oncol [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0137","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2007.03.005","article-title":"RNAi therapeutics: principles, prospects and challenges.","volume":"59","author":"Aagaard","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.tranon.2021.101101_bib0138","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jconrel.2013.09.027","article-title":"Enhanced hepatic delivery of siRNA and microRNA using oleic acid based lipid nanoparticle formulations","volume":"172","author":"Wang","year":"2013","journal-title":"J Control Release [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0139","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1007\/s13277-015-3075-1","article-title":"MicroRNA-15a induces cell apoptosis and inhibits metastasis by targeting BCL2L2 in non-small cell lung cancer","volume":"36","author":"Yang","year":"2015","journal-title":"Tumor Biol. [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0140","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev-pharmtox-010814-124630","article-title":"Therapeutic applications of extracellular vesicles: clinical promise and open questions","volume":"55","author":"Gy\u00f6rgy","year":"2015","journal-title":"Annu Rev Pharmacol Toxicol [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0141","article-title":"Focus on extracellular vesicles: Introducing the next small big thing","volume":"17","author":"Kalra","year":"2016","journal-title":"Int. J. Mol. Sci. [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0142","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nmeth.1682","article-title":"Toward the blood-borne miRNome of human diseases","volume":"8","author":"Keller","year":"2011","journal-title":"Nat. Methods [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0143","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/jcsm.12552","article-title":"Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 12th Cachexia Conference","author":"Ebner","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0144","first-page":"304","article-title":"Is it possible to overcome issues of external validity in preclinical animal research? Why most animal models are bound to fail [Internet]","author":"Pound","year":"2018","journal-title":"J. Transl. Med. BioMed Central Ltd."},{"key":"10.1016\/j.tranon.2021.101101_bib0145","first-page":"1","article-title":"Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia - can findings from animal models be translated to humans?","volume":"16","author":"Mueller","year":"2016","journal-title":"BMC Cancer [Internet]"},{"key":"10.1016\/j.tranon.2021.101101_bib0146","first-page":"157","article-title":"MicroRNAs as potential therapeutic targets for muscle wasting during cancer cachexia","volume":"23","author":"Sannicandro","year":"2020","journal-title":"Curr Opin Clin Nutr Metab Care. NLM (Medline);"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523321000930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523321000930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T14:44:22Z","timestamp":1761835462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523321000930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":146,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1936523321000930"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2021.101101","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-coding RNAs in cancer-associated cachexia: clinical implications and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2021.101101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101101"}}